The present study suggest that BaP can reverse the effects of drugs on cancer cells, including apoptosis, and this may be mediated by the activation of survival pathways such as MEK-ERK and Akt pathways in addition to upregulation of proteins such as Bcl-2 and Bcl-xL. This evidence concerns the gene BCL2L1 and cancer.